tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
LAVA Therapeutics Agrees to Acquisition by XOMA
PremiumCompany AnnouncementsLAVA Therapeutics Agrees to Acquisition by XOMA
1M ago
Xoma to acquire Lava Therapeutics for $1.16-$1.24 per share in cash plus CVR
Premium
The Fly
Xoma to acquire Lava Therapeutics for $1.16-$1.24 per share in cash plus CVR
1M ago
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors
Premium
Company Announcements
Lava Therapeutics’ LAVA-1207 Study Terminated: Implications for Investors
1M ago
Hold Rating for LAVA Therapeutics Amid Strategic Review and LAVA-1266 Progress
PremiumRatingsHold Rating for LAVA Therapeutics Amid Strategic Review and LAVA-1266 Progress
5M ago
Lava Therapeutics Reports 2024 Financial Results
Premium
Company Announcements
Lava Therapeutics Reports 2024 Financial Results
5M ago
Lava Therapeutics reports Q4 EPS (14c) vs. (24c) last year
Premium
The Fly
Lava Therapeutics reports Q4 EPS (14c) vs. (24c) last year
6M ago
Lava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyLava Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
6M ago
Lava Therapeutics implements restructuring plan, workforce reduction of 30%
Premium
The Fly
Lava Therapeutics implements restructuring plan, workforce reduction of 30%
7M ago
LAVA Therapeutics Announces Restructuring Plan for 2025
Premium
Company Announcements
LAVA Therapeutics Announces Restructuring Plan for 2025
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100